RIGL
RIGEL PHARMACEUTICALS INC
Latest close $40.48 as of Aug 5, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 4 parsed filing(s) · 1 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Group CIK0000102909 | Mar 13, 2026 observed Mar 27, 2026 filed · 14d Schedule 13G amendment | Earliest Schedule 13G amendment found | 11 | 12.00% | $25.95 | $25.81 | $40.48 |
| State Street CIK0000093751 | Dec 31, 2025 observed Feb 9, 2026 filed · 40d Initial Schedule 13G | Initial Schedule 13G | 1.1M | 12.00% | $42.83 | $34.41 | $40.48 |
| Invesco CIK0000914208 | Dec 31, 2024 observed Feb 7, 2025 filed · 38d Schedule 13G amendment | Reported reduction | 6.4K -1.0M | 12.00% +6.00 pts | $40.48 |